Alpha-Herpesvirus Thymidine Kinase Genes Mediate Viral Virulence and Are Potential Therapeutic Targets

Ying Xie(Sichuan Agricultural University), Liping Wu(Sichuan Agricultural University), Mingshu Wang(Sichuan Agricultural University), Anchun Cheng(Sichuan Agricultural University), Qiao Yang(Sichuan Agricultural University), Ying Wu(Sichuan Agricultural University), Renyong Jia(Sichuan Agricultural University), Dekang Zhu(Sichuan Agricultural University), Xinxin Zhao(Sichuan Agricultural University), Shun Chen(Sichuan Agricultural University), Mafeng Liu(Sichuan Agricultural University), Shaqiu Zhang(Sichuan Agricultural University), Yin Wang(Sichuan Agricultural University), Zhiwen Xu(Sichuan Agricultural University), Zhengli Chen(Sichuan Agricultural University), Ling Zhu(Sichuan Agricultural University), Qihui Luo(Sichuan Agricultural University), Yunya Liu(Sichuan Agricultural University), Yanling Yu(Sichuan Agricultural University), Ling Zhang(Sichuan Agricultural University), Xiaoyue Chen(Sichuan Agricultural University)
Frontiers in Microbiology
May 8, 2019
Cited by 58Open Access
Full Text

Abstract

Alpha-herpesvirus thymidine kinase (TK) genes are virulence-related genes and are nonessential for viral replication; they are often preferred target genes for the construction of gene-deleted attenuated vaccines and genetically engineered vectors for inserting and expressing foreign genes. The enzymes encoded by TK genes are key kinases in the nucleoside salvage pathway and have significant substrate diversity, especially the herpes simplex virus 1 (HSV-1) TK enzyme, which phosphorylates four nucleosides and various nucleoside analogues. Hence, the HSV-1 TK gene is exploited for the treatment of viral infections, as a suicide gene in antitumor therapy, and even for the regulation of stem cell transplantation and treatment of parasitic infection. This review introduces the effects of α-herpesvirus TK genes on viral virulence and infection in the host and classifies and summarizes the current main application domains and potential uses of these genes. In particular, mechanisms of action, clinical limitations, and antiviral and antitumor therapy development strategies are discussed.


Related Papers

No related papers found

Powered by citation graph analysis